Accuray Incorporated shares rise 3.21% intraday after announcing an analyst event at the American Society of Radiation Oncology.

Accuray Incorporated rose 3.21% in intraday trading, with the company announcing that it will host an analyst event at the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California. The event will feature global key opinion leaders sharing their perspectives on the role of adaptive radiotherapy in radiation medicine, which is likely to have a positive impact on the company's stock price.